2 hours ago · China
A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial
What's happening
SignalsMonitor is following this as a general story. South China Morning Post Asia is the outlet attached so far. The reports are tied to China. The first report grouped here was at 6 Nov 2026, 13:00 UTC. The headline in use is “A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
For people living with refractory epilepsy, the brain is like a city that can suffer a blackout any time lightning strikes. Without warning, an abnormal neural discharge can sweep through the intracranial circuits, leaving behind convulsions, loss of consciousness and years of lingering panic.
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by South China Morning Post Asia
A kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial
Reported by 1 outlet
- South China Morning Post
- South China Morning PostA kill switch for epilepsy? China cuts seizures by 92.6% in first human chemogenetic trial